Mixture of anti-HIV drugs may be used to treat nCoV patients in India

Image
ANI General News
Last Updated : Feb 05 2020 | 8:55 PM IST

New Delhi [India], Feb 5 (ANI): In a significant move, the India Council of Medical Research (ICMR) has sought an emergency approval from Central Drug Control Organisation (CDCSO) to use combination of anti-HIV drugs- 'Lopinavir and Ritonavir' tablets for the treatment of novel coronavirus (nCoV) patients in India, sources said.

This is only for restrictive use in the interest of the public health emergency.

"This decision has been taken in the recent meetings over the preparedness action on novel coronavirus. The Drugs Controller General of India (DCGI) has approved to use the combination of 'Lopinavir and Ritonavir' tablets for the treatment of nCoV patients for restrictive use in the interest of the public health emergency," sources told ANI.

"As of now, there is no specific drug or vaccine to treat patients of coronavirus. Doctors across the globe are treating respiratory patients with supportive medication following the clinical guidelines of WHO," soured said.

According to the latest data by the Union Health Ministry, about 5123 people are under observation (community surveillance) across the country out of which 128 patients are hospitalised for suspected coronavirus infection.

So far in India, three medical students who returned to Kerala from China have confirmed positive for nCoV and all three patients are receiving treatment under quarantine in the state.

According to WHO, coronaviruses are large families of viruses, which cause illnesses to people and also circulate in animals including camels, cats, and bats. Rarely, animal coronaviruses can also evolve and infect people. The epicentre of the disease is mainland china's Wuhan City, which has infected over 15000 people and claimed more than 450 lives so far in China.

Meanwhile, a randomised controlled clinical trial is now underway in China to test the anti-HIV drugs' efficacy, according to a study published in the Lancet Journal on January 24.

Last week, the Central government brought back about 600 Indian nationals (most of them are students) from China amid the outbreak of novel coronavirus. Approximately, 248 people are quarantined at Army's Manesar camp, out of which 6 persons are sent to Base Hospital for further observation after they showed flu-like symptoms. Meanwhile, 406 persons have been quarantined at ITBP's isolation facility and 5 persons have been shifted to Safdarjung Hospital for medical care.

Also, as a part of preventive measures to stop the spread of the disease, the Central government has suspended all visas for travel to China, which were issued earlier.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 05 2020 | 8:42 PM IST

Next Story